课题基金 / 基金详情

项目摘要

项目成果

ALI KESHAVARZIAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT For ITM 3.0, we request continued funding for the TL1 Postdoctoral Program, which over the past five years has provided training in clinical research and biomedical informatics to 18 postdoctoral fellows. This current postdoctoral TL1 program was begun in 2017, replacing an earlier predoctoral program; it is comprised of collaborating programs at UChicago and Rush, and its goal has been to prepare postdoctoral trainees for careers as independent and collaborative translational researchers through the integration of clinical research and biomedical informatics training. For ITM 3.0, we will build on the existing program structure and new training opportunities in clinical research, biomedical informatics, and public health to offer interdisciplinary postdoctoral research training that provides fellows with a guiding framework and skillset to help advance health toward health equity through translational research. The new iteration of this program, called the TL1 Postdoctoral Training Program in Clinical Research, Biomedical Informatics, and Health Equity, will incorporate research training opportunities at UChicago, Rush, and Loyola University Chicago to offer didactic training in clinical research, informatics, and public health. In addition, the program will provide faculty-mentored research opportunities and peer learning opportunities. Postdoctoral training programs such as the TL1 are critical to building a strong, enduring pipeline for developing the next generation of leaders in clinical and translational research who prioritize advancing health toward health equity as a goal of their research. To date, 11% of TL1 postdoctoral trainees have self-identified as a member of an underrepresented minority group. In ITM 3.0, we will redouble our effort to attract trainees who self-identify as under-represented minorities. Trainees will engage in this postdoctoral program after completing predoctoral training in graduate or medical school, and before a faculty appointment. The purpose of this postdoctoral training is to provide protected time and tuition support for early-career investigators to pursue advanced coursework and engage in mentored research, so they can successfully compete for faculty jobs, career development awards, and independent research funding.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
Hospital to Nursing Home Transitions of Care for Older Adults With Opioid Use Disorders: A Needs Assessment.
患有阿片类药物使用障碍的老年人从医院到疗养院的护理过渡:需求评估。
DOI: 10.1016/j.jamda.2021.01.049
发表时间: 2021
期刊: Journal of the American Medical Directors Association
影响因子: 7.6
作者: [Yang,Meredith, Yang,M, Beiting,K, Levine,S]
通讯作者: Levine,S
Invoking death: How oncologists discuss a deadly outcome.
援引死亡:肿瘤学家如何讨论致命的结果。
DOI: 10.1016/j.socscimed.2019.112672
发表时间: 2020
期刊: Social science & medicine (1982)
影响因子: --
作者: [Tate,Alexandra]
通讯作者: Tate,Alexandra
Maneuvering Clinical Pathways for Crohn's Disease.
克罗恩病的临床治疗路径。
DOI: 10.1007/s11894-019-0687-4
发表时间: 2019
期刊: Current gastroenterology reports
影响因子: --
作者: [Lu,ThomasX, Cohen,RussellD]
通讯作者: Cohen,RussellD
DOI: 10.5946/ce.2023.031
发表时间: 2024-01
期刊: Clinical endoscopy
影响因子: 2.5
作者: [Zilberstein N, Godbee M, Mehta NA, Waxman I]
通讯作者: Waxman I
15
    Center for Circadian Rhythms and Alcohol-Induced Tissue Damage
    • 批准号:
      10643983
    • 项目类别:
    • 资助金额:
      $41.94万
    • 财政年份:
      2019
    • 负责人:
      ALI KESHAVARZIAN
    • 依托单位:
    Center for Circadian Rhythms and Alcohol-Induced Tissue Damage
    • 批准号:
      10188343
    • 项目类别:
    • 资助金额:
      $41.94万
    • 财政年份:
      2019
    • 负责人:
      ALI KESHAVARZIAN
    • 依托单位:
    Alcohol Misuse: An Independent Risk Factor that Increases the Incidence and Severity of COVID-19
    • 批准号:
      10163399
    • 项目类别:
    • 资助金额:
      $31.39万
    • 财政年份:
      2019
    • 负责人:
      ALI KESHAVARZIAN
    • 依托单位:
    Center for Circadian Rhythms and Alcohol-Induced Tissue Damage
    • 批准号:
      10430302
    • 项目类别:
    • 资助金额:
      $31.39万
    • 财政年份:
      2019
    • 负责人:
      ALI KESHAVARZIAN
    • 依托单位:
    海外基金